Caring Brands, Inc. CABR PHARMA
Company Overview
Caring Brands, Inc., a wellness consumer products company, provides over-the-counter and cosmetic consumer products. It offers Hair Enzyme Booster (JW-700) for the treatment of hair growth; Photocil for the treatment of psoriasis and vitiligo; and CB-101 (Eczema Treatment) for atopic dermatitis (eczema). The company also offers NoStingz for the protection from jellyfish, sea lice, and UVA/UVB rays; and GoldN for Ebola diagnostics, as well as provides vitiligo solutions and women's sexual wellness products. Caring Brands, Inc., was incorporated in 2020 and is based in Fort Pierce, Florida.
Recent Developments
- Dec 2025 Revenue of $4.21K (+806.5% YoY); net profit $-6.28M.
- Trailing 12 Months Year-on-year growth — revenue +806.5%.
- 5-Year Trend Long-term compounding — revenue CAGR -54.6%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -54.57% |
| 1 Year: | 806.45% |
Stock Price Performance
| 1 Year: | +33.25% |
| 6 Months: | +37.04% |
| 3 Months: | -7.50% |
| 1 Month: | -16.85% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)36.32 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Revenue declined at -54.6% CAGR over 5 years.
- Trading 31.1% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Healthcare).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | CABR Caring Brands, Inc. PHARMA | 1.11 | -1.42 | $11.51M | 0.00% | - | - | -54.57% | - |
| 2 | LLY Eli Lilly and Company SPXR3KPHARMA | 1,123.91 | 37.80 | $1.00T | 0.60% | - | 102.29% | 7.20% | 11.41% |
| 3 | JNJ Johnson & Johnson SPXR3KPHARMA | 269.12 | 31.22 | $648.55B | 1.98% | 14.88% | 25.74% | 2.43% | 4.76% |
| 4 | ABBV AbbVie Inc. SPXR3KPHARMA | 248.78 | 70.48 | $439.62B | 2.78% | 10.47% | -129.24% | 1.75% | -29.06% |
| 5 | MRK Merck & Co., Inc. SPXR3KPHARMA | 148.46 | 118.77 | $366.28B | 2.31% | - | 6.96% | 5.64% | 10.01% |
| 6 | UNH UnitedHealth Group Incorporated SPXR3KPHARMA | 400.84 | 25.74 | $359.79B | 2.47% | 9.74% | 14.15% | 10.40% | 5.43% |
| 7 | NVS Novartis AG PHARMA | 137.70 | 20.80 | $261.73B | 3.36% | 21.09% | 30.35% | 9.25% | 26.22% |
| 8 | AZN AstraZeneca PLC NDXPHARMA | 160.04 | 23.99 | $248.20B | 2.00% | 15.97% | 21.96% | 9.82% | 45.96% |
| 9 | TMO Thermo Fisher Scientific Inc. SPXR3KPHARMA | 603.02 | 32.49 | $222.97B | 0.29% | 8.14% | 13.51% | 8.81% | 12.95% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Revenue | - | - | 1.47K | 1.59K | 740 | 420 | 0 |
| Cost of Revenue | - | - | 678 | 722 | 292 | 181 | 0 |
| Gross Profit | - | - | 791 | 865 | 448 | 239 | 0 |
| Operating Expenses | - | - | 540.13K | 660.45K | 999.92K | 1.19M | 1.72M |
| Operating Income | -156.09K | - | -539.34K | -659.58K | -999.48K | -1.19M | -1.72M |
| EBITDA | - | - | -464.34K | -584.58K | -924.48K | -1.11M | -1.72M |
| Interest Expense | - | - | - | - | - | - | - |
| Pretax Income | - | - | -538.77K | -660.58K | -1.02M | -4.06M | -2.01M |
| Tax Provision | - | - | - | - | - | - | - |
| Net Income | -156.16K | - | -538.77K | -660.58K | -1.02M | -4.06M | -3.85M |
| Diluted EPS | - | -0.06 | -0.04 | - | -0.08 | - | -0.27 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Revenue | 20.42K | 465 | 4.21K |
| Cost of Revenue | 118.87K | 2.07K | 1.87K |
| Gross Profit | -98.45K | -1.61K | 2.34K |
| Operating Expenses | 52.94K | 1.53M | 3.39M |
| Operating Income | -151.39K | -1.53M | -3.39M |
| EBITDA | -149.19K | -1.38M | -3.09M |
| Interest Expense | - | - | - |
| Pretax Income | -128.09K | -1.52M | -6.28M |
| Tax Provision | - | - | - |
| Net Income | -128.09K | -1.52M | -6.28M |
| Diluted EPS | -0.01 | -0.11 | -0.46 |
| R&D Expense | - | 39.56K | 0 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2023 | Sep 2024 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Total Assets | - | - | 3.88M | 2.33M |
| Total Equity | -265.77K | -920.41K | 3.69M | 2.09M |
| Cash & Equivalents | - | - | 469.00K | 2.19M |
| Long Term Debt | - | - | - | 58.65K |
| Total Liabilities | - | - | 186.10K | 235.49K |
| Current Liabilities | - | - | 186.10K | 176.84K |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2025 |
|---|---|
| Operating Cash Flow | -1.69M |
| Financing Cash Flow | 3.41M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Gross Margin % | -482.1% | -345.6% | 55.6% |
| Operating Margin % | -741.4% | -328,471.8% | -80,309.0% |
| Net Margin % | -627.2% | -326,329.2% | -148,948.8% |
| ROE % | 48.2% | -41.1% | -300.2% |
| ROCE % | - | -41.4% | -157.4% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Franklin Resources, Inc. | 0.26% | 35.97K | $50.36K |
| 2 | Vanguard Capital Management LLC | 0.19% | 26.16K | $36.62K |
| 3 | Geode Capital Management, LLC | 0.18% | 24.94K | $34.91K |
| 4 | Susquehanna International Group, LLP | 0.15% | 20.77K | $29.08K |
| 5 | Xtx Topco Ltd | 0.13% | 18.48K | $25.88K |
| 6 | Jane Street Group, LLC | 0.11% | 15.65K | $21.91K |
| 7 | LPL Financial LLC | 0.07% | 10.00K | $14.00K |
| 8 | UBS Group AG | 0.03% | 3.52K | $4.93K |
| 9 | Tower Research Capital LLC (TRC) | 0.02% | 2.46K | $3.44K |
| 10 | Caitong International Asset Management Co., Ltd | - | 1 | $1 |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CABR
Caring Brands Inc. (Nasdaq: CABR) Completes Initial $4.6 Million Closing Under Ongoing $9 Million Private Placement - finance.yahoo.com
<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxPd3hJdkpfSC01Z044M0tCZ3M3YTd0NjBaa2JjS21hdG1zdzJfNHlEbUoxWk9VeUVSUGIwbHdqZEI1eGZfLVl2dUY2bjd2eGpDbVNub3ItdEhNSnZuY3pxb0Y3dTZEektuMHA5VnNxU29PVWZuYUJ5aEpRaFhTN2RFZlpZSUtHWlF5R0tvbF…
Caring Brands (CABR) interim CFO reports 150,000-share issuer redemption at $1.00 - Stock Titan
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxQZERaanhQa2c2UVhvLW9kMnhOUFpNOVJVeXFLSWpVQ0d0cnBTaExSQmtMNjhmbDJVR21NTGxYSnVvbzltbnpKTUNjY0tWVU5oTUxUSElSN3lLRUlueXl0OE16MkRvZEMzX3FVZFllNHBEbXlWVkxuNkR6TW5Daktjck1GajcyY254eHlQaV…
Caring Brands, Inc. Common Stock (NASDAQ: CABR) Share Price, CABR Stock News, CABR Share Price & Updates - kalkine.com.au
<a href="https://news.google.com/rss/articles/CBMiVkFVX3lxTE5jb2dnQVpGN2J2RWhteGV5NGhyNEU1QUhqZC02VDNxOVhQNmNlRzM5ZFRPUGlNSV9JbDI4YVhjSDNBQXU0bkp0eExGZ25Tb00ySEF2OTln?oc=5" target="_blank">Caring Brands, Inc. Common Stock (NASDAQ: CABR) Sha…
Caring Brands, Inc. Common Stock (NASDAQ: CABR) Share Price, CABR Stock News, CABR Share Price & Updates - kalkine.ca
<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTFBWYWdra0dMRW1DclJKcWFUc05iY1ZpbzhEQklUMENnYkdCclBSZ1JqaTF2ZlAtOENHNzVKWGRYNkhuMTBQdUtEV0pLTlVOMDJX?oc=5" target="_blank">Caring Brands, Inc. Common Stock (NASDAQ: CABR) Share Price…
CABR Stock Price and Chart — NASDAQ:CABR - tradingview.com
<a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTFBqbWthMk5EUmhERklZVVpUZ2JYTmpfenZoTVI2bDF6V0o1ZjN6eFJyLWpIZkd1bHF4M2ZvQWlSRk1FVVFZUXoyMGhBMVY3M2Q0UUktTXZoazdtOFBC?oc=5" target="_blank">CABR Stock Price and Chart — NASDAQ:CABR</a…
Caring Brands (NASDAQ: CABR) Secures $4.6M in Initial Series B Preferred Stock Private Placement - Kalkine Media
<a href="https://news.google.com/rss/articles/CBMi1AFBVV95cUxNZG8xWEVxQXJvMG52Y0NOaFVmMjhZYzRQczdTM2l1dm5HeERVdHFqNlE5amwxa2g1YkdsSlNKc2FsSWhhMkxNZFdtcm1TSjI4dXNhWE43QlpHdmhVeFlESmM4TmdVcnJBWnJ1UHFXNVotXzd0MkpTN0V6bEQxVTB1TFBiWVJHWlkwT09DRU…
CABR — Frequently Asked Questions
What is the current share price of Caring Brands, Inc. (CABR)?
As of 2026-09-19 21:16 PDT, Caring Brands, Inc. (CABR) trades at $1.11 on NasdaqCM. Its 52-week range is $0.74 to $1.61.
What is the market capitalisation of CABR?
Caring Brands, Inc. (CABR) has a market capitalisation of $11.51M on NasdaqCM.
What is the P/E ratio of CABR?
CABR trades at a trailing price-to-earnings (P/E) ratio of -1.42. The industry average P/E is 24.83. Its price-to-book (P/B) ratio is -3.76.
Is CABR a good stock to buy?
This page provides a data-driven analysis of Caring Brands, Inc. (CABR), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.